|Bid||33.00 x 900|
|Ask||49.00 x 2200|
|Day's Range||45.49 - 46.59|
|52 Week Range||19.51 - 69.58|
|Beta (5Y Monthly)||3.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 02, 2021 - Nov. 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.83|
Surgery Partners, Inc. ( NASDAQ:SGRY ) shareholders might be concerned after seeing the share price drop 25% in the...
Surgery Partners (SGRY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Bain Capital Private Equity's Managing Director Devin O'Reilly explains why his firm sought out its new investment in PartSource and other investment areas Bain likes in the healthcare space.